Ceribell Rapid EEG alters the treatment course for patients with suspected seizures and will result in cost savings per patient.

  • Using PSA, Rapid-EEG saving was $5,633 per use case (95% PI: $($4,649 to $6,617)

  • Rapid EEG use led to reduction in the hospital LOS by 1.2 days (6.1 vs. 7.4 days) and ICU LOS by 0.4 days (1.5 vs. 1.9 day)

Dr. DaiWai Olson discusses real-world cases and nurse contribution for Rapid EEG to diagnose and treat NCSE in critical care (recorded at Ceribell’s Symposium at NCS 2019)

DaiWai Olson is a Distinguished Teaching Professor in the Department of Neurology and Neurological Surgery at UTSouthwestern Medical Center. Dr. Olson’s work is focused on developing a more comprehensive understanding of how nursing care contributes to patient outcomes following acquired brain injury. He has published over 250 manuscripts, 16 book chapters, and 150 scientific abstracts. He is the Editor-in-Chief for the Journal of Neuroscience Nursing and the co-chair of the international Neurocritical Care Research Network.

The Neurocritical Care Society (NCS) presents a FREE CME Source: An Interdisciplinary Approach to Managing Nonconvulsive Status Epilepticus

Speakers: Thomas Bleck, DaiWai Olson, Lawrence Hirsch, Karen Berger
Moderator: Gretchen Brophy

Please access the CME course via this link: https://www.pathlms.com/ncs-ondemand/courses/1815/video_presentations/173862?ut%E2%80%A6%20

The webinar covers the evolution of EEG monitoring with respect to changes in delegation of authority in the neurocritical care unit, the pharmacologic treatment options for status epilepticus (SE) and refractory status epilepticus (RSE), who should undergo urgent EEG for possible nonconvulsive status epilepticus, including when, why and for how long, and data on the management of nonconvulsive status epilepticus.

(more…)

Dr. Tom Bleck discusses NCSE diagnosis and management (recorded at Ceribell’s Symposium at NCS 2019)

Thomas P. Bleck, MD, MCCM, FNCS is a Professor of Neurology at Northwestern University Feinberg School of Medicine and Professor Emeritus of Neurological Sciences, Neurosurgery, Medicine, and Anesthesiology at Rush Medical College. Dr. Bleck was the founding president of the Neurocritical Care Society and is an ex officio member of the board of directors. He is the associate editor of Critical Care Medicine, and serves on the editorial boards of several other journals.

Dr. Paul Vespa, Assistant Dean of Critical Care Medicine, Research and David Geffen School of Medicine, UCLA and Gary L. Brinderson Family Chair in Neurocritical Care at David Geffen School of Medicine, UCLA and co-author of the DECIDE paper presents the study.

  • Ceribell™ Rapid Response EEG was demonstrated to significantly improve clinical accuracy and confidence

    • A substantial number of critically ill patients with altered mental status have nonconvulsive seizures; data suggests a clear association between prolonged nonconvulsive seizures and poor neurologic outcomes
    • However, even in large academic medical centers with 24/7 in-house EEG technologists, access to conventional EEG is often delayed by several hours
    • Rapid-EEG resulted in substantial changes in physician decision making compared with clinical judgment alone and improved the sensitivity and specificity of physician judgments regarding the presence or absence of nonconvulsive seizure activity
    • Early access to EEG will lead to early detection, and hence, more effective treatment of seizures, which will in turn prevent refractory status epilepticus; neuronal injury; and potentially deleterious impacts on patient morbidity, mortality, and long-term outcome

Dr. Josef Parvizi, Professor of Neurology at Stanford and co-author of the Ceribell Clarity AI paper presents the study.

  • Of the 179 EEG recordings in which Claritγ detected no seizures, [Clarity had a] negative predictive value of 99%.
  • Individual expert raters displayed variability in both sensitivity (range 20–89%) and specificity (range 94–99%).
  • The sensitivity for identifying status epilepticus was 100%, [and] the specificity of the ≥ 90% seizure burden notification was 93.0%.

Dr. James Quinn, Professor of Emergency Medicine at Stanford and co-author of the Ceribell Clarity AI paper presents the study.

  • Of the 179 EEG recordings in which Claritγ detected no seizures, [Clarity had a] negative predictive value of 99%.
  • Individual expert raters displayed variability in both sensitivity (range 20–89%) and specificity (range 94–99%).
  • The sensitivity for identifying status epilepticus was 100%, [and] the specificity of the ≥ 90% seizure burden notification was 93.0%.

Parshaw Dorriz shares real-world experiences: Impact of Ceribell Rapid Response EEG

Dr Dorriz is the Chief of Neurology at Mission Hospital in Mission Viejo, California.